Rondina, Jessa B.

HRN: 16-84-06  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/06/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/06/2026
04/12/2026
IVT
500MG
Q 8 HRS
TMSAF
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: